Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-23

Clinical Trial Update: Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test. [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating AEZS-130 as an oral growth hormone secretagogue for growth hormone stimulation testing in adults with growth hormone deficiency ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AEZS-130 (growth hormone secretagogue)

Snippet

Sponsor: AEterna Zentaris | Conditions: Diagnosis of Adult Growth Hormone Deficiency (AGDH) | Phase 3 | Status: COMPLETED | Results posted: 2019-07-23